The article reports on the use of triple-antibiotic therapy for Crohn's disease in Australia. Centre for Digestive Diseases director Thomas Borody supports triple-antibiotic therapy for Crohn's disease. He is seen by patients as a hero, but is being ostracized by many gastroenterologists because conventional wisdowm holds that Crohn's disease is a heterogenous disease caused by abnormally aggresive immune response to common enteric bacteria.